MARKET

IVA

IVA

Inventiva S.A.
NASDAQ
4.760
+0.110
+2.37%
After Hours: 4.800 +0.04 +0.84% 19:34 01/02 EST
OPEN
4.650
PREV CLOSE
4.650
HIGH
4.900
LOW
4.605
VOLUME
201.94K
TURNOVER
--
52 WEEK HIGH
7.98
52 WEEK LOW
2.111
MARKET CAP
908.00M
P/E (TTM)
-1.1186
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IVA last week (1222-1226)?
Weekly Report · 12/29/2025 09:54
Weekly Report: what happened at IVA last week (1215-1219)?
Weekly Report · 12/22/2025 09:54
Inventiva SA to Present Corporate Overview at J.P. Morgan Healthcare Conference
Reuters · 12/17/2025 21:00
Weekly Report: what happened at IVA last week (1208-1212)?
Weekly Report · 12/15/2025 09:59
Weekly Report: what happened at IVA last week (1201-1205)?
Weekly Report · 12/08/2025 09:58
Weekly Report: what happened at IVA last week (1124-1128)?
Weekly Report · 12/01/2025 09:55
Tilray Brands, SuperX AI Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga · 11/28/2025 13:17
Inventiva’s Shareholders’ Meeting Results in Key Resolutions Approval
TipRanks · 11/28/2025 11:30
More
About IVA
Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.

Webull offers Inventiva SA stock information, including NASDAQ: IVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVA stock methods without spending real money on the virtual paper trading platform.